Terms: = Germ cell tumor AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Treatment
177 results:
1. treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
Atkins MB; Jegede OA; Haas NB; Mcdermott DF; Bilen MA; Stein M; Sosman J; Alter R; Plimack ER; Ornstein MC; Hurwitz M; Peace DJ; Einstein D; Catalano PJ; Hammers H; Regan MM
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604810
[TBL] [Abstract] [Full Text] [Related]
2. Endoscopic treatments for rectal neuroendocrine tumors: a systematic review and network meta-analysis.
Chen J; Ye J; Zheng X; Chen J
J Gastrointest Surg; 2024 Mar; 28(3):301-308. PubMed ID: 38445925
[TBL] [Abstract] [Full Text] [Related]
3. MZ1, a brd4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma.
Li G; Ma L; Feng C; Yin H; Bao J; Wu D; Zhang Z; Li X; Li Z; Yang C; Wang H; Fang F; Hu X; Li M; Xu L; Xu Y; Liang H; Yang T; Wang J; Pan J
BMC Cancer; 2024 Feb; 24(1):220. PubMed ID: 38365636
[TBL] [Abstract] [Full Text] [Related]
4. Development and evaluation of multi-functionalized sialic acid conjugated asiatic acid nanoconstruct to mitigate cognitive deficits in Alzheimer's disease.
Halder T; Saha B; Dhas N; Acharya S; Acharya N
Drug Dev Res; 2024 Feb; 85(1):e22146. PubMed ID: 38349270
[TBL] [Abstract] [Full Text] [Related]
5. Comparative assessment of direct and indirect cold atmospheric plasma effects, based on helium and argon, on human glioblastoma: an in vitro and in vivo study.
Bakhtiyari-Ramezani M; Nohekhan M; Akbari ME; Abbasvandi F; Bayat M; Akbari A; Nasiri M
Sci Rep; 2024 Feb; 14(1):3578. PubMed ID: 38347045
[TBL] [Abstract] [Full Text] [Related]
6. Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study.
Trautwein NF; Hinterleitner C; Kiefer LS; Singer S; Mattern S; Schwenck J; Reischl G; Sipos B; Lauer UM; Dittmann H; Zender L; la Fougère C; Hinterleitner M
Clin Nucl Med; 2024 Mar; 49(3):207-214. PubMed ID: 38271237
[TBL] [Abstract] [Full Text] [Related]
7. Cold atmospheric plasma (cap) treatment increased reactive oxygen and nitrogen species (RONS) levels in tumor samples obtained from patients with low-grade glioma.
Aggarwal Y; Vaid A; Visani A; Rane R; Joseph A; Mukherjee S; Tripathi M; Chandra PS; Doddamani R; Dixit AB; Banerjee J
Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38241730
[TBL] [Abstract] [Full Text] [Related]
8. Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1.
Hu R; Hou H; Li Y; Zhang M; Li X; Chen Y; Guo Y; Sun H; Zhao S; Liao M; Cao D; Yan Q; Chen X; Yin M
Theranostics; 2024; 14(2):593-607. PubMed ID: 38169595
[No Abstract] [Full Text] [Related]
9. Cold atmospheric plasma sensitizes melanoma cells to targeted therapy agents in vitro.
Yan C; Zhao L; Zhang X; Chu Z; Zhou T; Zhang Y; Geng S; Guo K
J Biophotonics; 2024 Mar; 17(3):e202300356. PubMed ID: 38041219
[TBL] [Abstract] [Full Text] [Related]
10. Biomineralized Polydopamine Nanoparticle-Based Sodium Alginate Hydrogels for Delivery of Anti-serine/Threonine Protein Kinase B-Rapidly Accelerated Fibrosarcoma siRNA for Metastatic Melanoma Therapy.
Lu J; Song J; Zhang P; Huang Y; Lu X; Dai H; Xi J
ACS Nano; 2023 Sep; 17(18):18318-18331. PubMed ID: 37690074
[TBL] [Abstract] [Full Text] [Related]
11. Discovery of a potent, orally available tricyclic derivative as a novel brd4 inhibitor for melanoma.
Horai Y; Suda N; Uchihashi S; Katakuse M; Shigeno T; Hirano T; Takahara J; Fujita T; Mukoyama Y; Haga Y
Bioorg Med Chem; 2023 Oct; 93():117461. PubMed ID: 37659219
[TBL] [Abstract] [Full Text] [Related]
12. Increased radiosensitivity of melanoma cells through cold plasma pretreatment mediated by ICG.
Momeni S; Shanei A; Sazgarnia A; Azmoonfar R; Ghorbani F
J Radiat Res; 2023 Sep; 64(5):751-760. PubMed ID: 37586714
[TBL] [Abstract] [Full Text] [Related]
13. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
[TBL] [Abstract] [Full Text] [Related]
14. Induction of glioblastoma cell ferroptosis using combined treatment with chloramphenicol and 2-deoxy-D-glucose.
Miki K; Yagi M; Noguchi N; Do Y; Otsuji R; Kuga D; Kang D; Yoshimoto K; Uchiumi T
Sci Rep; 2023 Jun; 13(1):10497. PubMed ID: 37380755
[TBL] [Abstract] [Full Text] [Related]
15. Camrelizumab Plus Apatinib and Temozolomide as First-Line treatment in Patients With Advanced Acral Melanoma: The cap 03 Phase 2 Nonrandomized Clinical Trial.
Mao L; Lian B; Li C; Bai X; Zhou L; Cui C; Chi Z; Sheng X; Wang X; Tang B; Yan X; Li S; Kong Y; Dai J; Wei X; Li J; Duan R; Xu H; Wu X; Yang Y; Cheng F; Zhang C; Xia F; Pang Z; Guo J; Si L
JAMA Oncol; 2023 Aug; 9(8):1099-1107. PubMed ID: 37261804
[TBL] [Abstract] [Full Text] [Related]
16. Anticancer Effect of Cold Atmospheric Plasma in Syngeneic Mouse Models of Melanoma and Colon Cancer.
Jung JM; Yoon HK; Kim SY; Yun MR; Kim GH; Lee WJ; Lee MW; Chang SE; Won CH
Molecules; 2023 May; 28(10):. PubMed ID: 37241912
[TBL] [Abstract] [Full Text] [Related]
17. CyberKnife Stereotactic Radiosurgery for Growing Vestibular Schwannoma: Longitudinal tumor Control, Hearing Outcomes, and Predicting Post-treatment Hearing Status.
Hildrew DM; Perez PL; Mady LJ; Li J; Nilsen ML; Hirsch BE
Laryngoscope; 2024 Jan; 134 Suppl 1():S1-S12. PubMed ID: 37178050
[TBL] [Abstract] [Full Text] [Related]
18. brd4: New hope in the battle against glioblastoma.
Duan W; Yu M; Chen J
Pharmacol Res; 2023 May; 191():106767. PubMed ID: 37061146
[TBL] [Abstract] [Full Text] [Related]
19. Radiation for Sporadic Vestibular Schwannoma: An Update on Modalities, Emphasizing Hearing Loss, Side Effects, and tumor Control.
Woodson E
Otolaryngol Clin North Am; 2023 Jun; 56(3):521-531. PubMed ID: 37019768
[TBL] [Abstract] [Full Text] [Related]
20. Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression.
Yang Z; Zheng Y; Wu H; Xie H; Zhao J; Chen Z; Li L; Yue X; Zhao B; Bian E
Hum Genomics; 2023 Mar; 17(1):33. PubMed ID: 37004060
[TBL] [Abstract] [Full Text] [Related]
[Next]
